Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
A Randomized Double Blind Placebo-Controlled Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
Status: Enrolling
Updated:  1/5/2016
Comprehensive Women's Care
mi
from
Colorado Springs, CO
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
A Randomized Double Blind Placebo-Controlled Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
Status: Enrolling
Updated: 1/5/2016
Comprehensive Women's Care
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
A Randomized Double Blind Placebo-Controlled Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
Status: Enrolling
Updated:  1/5/2016
Dittrich Clinic
mi
from
Philadelphia, PA
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
A Randomized Double Blind Placebo-Controlled Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
Status: Enrolling
Updated: 1/5/2016
Dittrich Clinic
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Flaxseed Lignan (Brevail)
Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome
Status: Enrolling
Updated:  1/6/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Flaxseed Lignan (Brevail)
Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome
Status: Enrolling
Updated: 1/6/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
OB Nest; Redefining Continuity of Care for Expectant Mothers
Implementation and Evaluation of the OB Nest Project at the Point of Care: Redefining Continuity of Care for Expectant Mothers.
Status: Enrolling
Updated:  1/7/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
OB Nest; Redefining Continuity of Care for Expectant Mothers
Implementation and Evaluation of the OB Nest Project at the Point of Care: Redefining Continuity of Care for Expectant Mothers.
Status: Enrolling
Updated: 1/7/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
University of South Alabama, Children's and Women's Hospital
mi
from
Mobile, AL
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
University of South Alabama, Children's and Women's Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
University of California - Irvine Medical Center
mi
from
Irvine, CA
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
University of California - Irvine Medical Center
mi
from
Irvine, CA
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
Georgia Regents Medical Center
mi
from
Augusta, GA
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
Georgia Regents Medical Center
mi
from
Augusta, GA
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
Vidant Medical Center
mi
from
Greenville, NC
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
West Virginia University Hospital
mi
from
Morgantown, WV
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
West Virginia University Hospital
mi
from
Morgantown, WV
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
University of Wisconsin - Madison
mi
from
Madision, WI
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
University of Wisconsin - Madison
mi
from
Madision, WI
Click here to add this to my saved trials
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated:  1/7/2016
D.A.I. Materno Infantile, S.O.D. Neonatologia e Terapia Intensiva Neonatale - Azienda Ospedaliero-Universitaria Careggi
mi
from
Firenze,
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
Status: Enrolling
Updated: 1/7/2016
D.A.I. Materno Infantile, S.O.D. Neonatologia e Terapia Intensiva Neonatale - Azienda Ospedaliero-Universitaria Careggi
mi
from
Firenze,
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Fountain Valley Regional Hospital and Medical Center- UCI MFM private practice
mi
from
Fountain Valley, CA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Fountain Valley Regional Hospital and Medical Center- UCI MFM private practice
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Long Beach Memorial Medical Center, Women's and Children's Hospital - Women's Perinatal Group, OB Clinic
mi
from
Long Beach, CA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Long Beach Memorial Medical Center, Women's and Children's Hospital - Women's Perinatal Group, OB Clinic
mi
from
Long Beach, CA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
University of California, Irvine, Medical Center - Prenatal care clinics and private practice
mi
from
Orange, CA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
University of California, Irvine, Medical Center - Prenatal care clinics and private practice
mi
from
Orange, CA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Christiana Care Health Systems
mi
from
Newark, DE
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Christiana Care Health Systems
mi
from
Newark, DE
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Indiana University School of Medicine OB/GYN
mi
from
Indianapolis, IN
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Indiana University School of Medicine OB/GYN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Columbia University Medical Center- Department of Obstetrics and Gynecology Division of Maternal Fetal Medicine
mi
from
New York, NY
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Columbia University Medical Center- Department of Obstetrics and Gynecology Division of Maternal Fetal Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Case Western Reserve University, MetroHealth Medical Center
mi
from
Cleveland, OH
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Case Western Reserve University, MetroHealth Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
McKay-Dee Hospital
mi
from
Ogden, UT
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
McKay-Dee Hospital
mi
from
Ogden, UT
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Utah Valley Regional Medical Center
mi
from
Provo, UT
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Utah Valley Regional Medical Center
mi
from
Provo, UT
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
LDS Hospital
mi
from
Salt Lake City, UT
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
University of Utah
mi
from
Salt Lake City, UT
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Northwestern University
mi
from
Chicago, IL
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated:  1/11/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk
Status: Enrolling
Updated: 1/11/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
Using Nimodipine, a Calcium Channel Blocker, to Prevent LH Surge in Women Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: a Double-blinded, Randomized Controlled Study
Status: Enrolling
Updated:  1/11/2016
Boston IVF
mi
from
Waltham, MA
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
Using Nimodipine, a Calcium Channel Blocker, to Prevent LH Surge in Women Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: a Double-blinded, Randomized Controlled Study
Status: Enrolling
Updated: 1/11/2016
Boston IVF
mi
from
Waltham, MA
Click here to add this to my saved trials
Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
OAG and Decitabine for Newly Diagnosed Acute Myeloid Leukemia Patients Greater Than or Equal to 65 Years of Age
Status: Enrolling
Updated:  1/11/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
OAG and Decitabine for Newly Diagnosed Acute Myeloid Leukemia Patients Greater Than or Equal to 65 Years of Age
Status: Enrolling
Updated: 1/11/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Cervical Activation During Elastic and Manual Resistance
EMG Activation of Cervical Musculature During Therapeutic Exercise With Thera-Band(R) Resistance Versus Manual Resistance
Status: Enrolling
Updated:  1/11/2016
Sport & Spine Rehab
mi
from
Rockville, MD
Cervical Activation During Elastic and Manual Resistance
EMG Activation of Cervical Musculature During Therapeutic Exercise With Thera-Band(R) Resistance Versus Manual Resistance
Status: Enrolling
Updated: 1/11/2016
Sport & Spine Rehab
mi
from
Rockville, MD
Click here to add this to my saved trials
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Status: Enrolling
Updated:  1/11/2016
Yale School of Medicine
mi
from
New Haven, CT
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Status: Enrolling
Updated: 1/11/2016
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Status: Enrolling
Updated:  1/12/2016
Brown University
mi
from
Providence, RI
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Status: Enrolling
Updated: 1/12/2016
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated:  1/13/2016
Federally Qualified Community Health Centers
mi
from
Jackson, MS
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated: 1/13/2016
Federally Qualified Community Health Centers
mi
from
Jackson, MS
Click here to add this to my saved trials
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated:  1/13/2016
Mississippi State Department of Health
mi
from
Jackson, MS
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated: 1/13/2016
Mississippi State Department of Health
mi
from
Jackson, MS
Click here to add this to my saved trials
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated:  1/13/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Interpregnancy Care Project-Mississippi (IPC-M)
Interpregnancy Care Project-Mississippi
Status: Enrolling
Updated: 1/13/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Protein and Ultrasound Indicators of Preterm Birth
Protein and Ultrasound Indicators of Preterm Birth
Status: Enrolling
Updated:  1/13/2016
University of Colorado Hospital
mi
from
Denver, CO
Protein and Ultrasound Indicators of Preterm Birth
Protein and Ultrasound Indicators of Preterm Birth
Status: Enrolling
Updated: 1/13/2016
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Smoking Cessation in Women With Gynecological Conditions
Immediate Smoking Cessation for Patients at Risk for Cervical Dysplasia, Cervical Cancer and Lower Genital Tract Dysplasia and Cancer - A Feasibility Study Comparing Nicotine Replacement Therapy With the Electronic Nicotine Delivery System.
Status: Enrolling
Updated:  1/13/2016
Stephenson Cancer Center
mi
from
Oklahoma City, OK
Smoking Cessation in Women With Gynecological Conditions
Immediate Smoking Cessation for Patients at Risk for Cervical Dysplasia, Cervical Cancer and Lower Genital Tract Dysplasia and Cancer - A Feasibility Study Comparing Nicotine Replacement Therapy With the Electronic Nicotine Delivery System.
Status: Enrolling
Updated: 1/13/2016
Stephenson Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Brain Imaging-based Strategies for Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Status: Enrolling
Updated:  1/13/2016
Northwestern University
mi
from
Chicago, IL
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Brain Imaging-based Strategies for Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Status: Enrolling
Updated: 1/13/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
St. Petersburg State University
mi
from
St. Peterburg,
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
St. Petersburg State University
mi
from
St. Peterburg,
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
University of Southern California
mi
from
Los Angeles, CA
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
Univ of Illinois
mi
from
Chicago, IL
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
University of Kentucky
mi
from
Lexington, KY
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
Johns Hopkins
mi
from
Baltimore, MD
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
University of Maryland
mi
from
Baltimore, MD
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated:  1/14/2016
Massachusetts General
mi
from
Boston, MA
Investigation in Pregnancy Associate Cardiomyopathy
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
Status: Enrolling
Updated: 1/14/2016
Massachusetts General
mi
from
Boston, MA
Click here to add this to my saved trials